Opioids in cancer: The κ‑opioid receptor (Review)
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Frontiers | Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
Special K: What the Real Scoop on Abuse and Addiction to Ketamine? - Women's Recovery
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
κ-opioid receptor - Wikipedia
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Life | Free Full-Text | Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
κ-opioid receptor - Wikipedia
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
Ketamine acts like an opioid, Stanford study suggests
VIC DRUG ALERT JUNE 2022
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
